Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United Kingdom
  4. London Stock Exchange
  5. Arix Bioscience plc
  6. Financials
    ARIX   GB00BD045071

ARIX BIOSCIENCE PLC

(ARIX)
  Report
Delayed Quote. Delayed London Stock Exchange - 07/23 11:35:19 am
176.5 GBX   --.--%
12:06pTransaction in own shares
DJ
07/21Notice of Results
DJ
07/19Transaction in own shares
DJ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2018 2019 2020 2021 2022
Capitalization1 208134286222-
Entreprise Value (EV)1 11780,117447,151,4
P/E ratio 5,61x-1,98x2,47x6,11x11,5x
Yield -----
Capitalization / Revenue 157x264x599x444x444x
EV / Revenue 87,9x158x365x94,2x103x
EV / EBITDA -----
Price to Book 0,83x0,71x0,91x0,64x0,59x
Nbr of stocks (in thousands) 124 871125 599130 529125 908-
Reference price (GBP) 1,671,072,191,771,77
Announcement Date 03/28/201903/10/202003/09/2021--
1 GBP in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2018 2019 2020 2021 2022
Net sales1 1,330,510,480,500,50
EBITDA -----
Operating profit (EBIT)1 40,8-70,6128-0,307,15
Operating Margin 3 073%-13 959%26 831%-60,0%1 430%
Pre-Tax Profit (EBT)1 42,8-75,612637,720,0
Net income1 36,9-69,912637,720,0
Net margin 2 777%-13 808%26 431%7 540%4 000%
EPS2 0,30-0,540,890,290,15
Dividend per Share2 -----
Announcement Date 03/28/201903/10/202003/09/2021--
1 GBP in Million
2 GBP
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2017 S2 2018 S2
Net sales1 1,280,86
EBITDA --
Operating profit (EBIT)1 -10,9
Operating Margin -1 272%
Pre-Tax Profit (EBT)1 -13,5
Net income1 -11,2
Net margin -1 309%
EPS2 -0,08
Dividend per Share --
Announcement Date 04/23/201803/28/2019
1 GBP in Million
2 GBP
Balance Sheet Analysis
Fiscal Period: December 2018 2019 2020 2021 2022
Net Debt1 -----
Net Cash position1 91,253,7112175171
Leverage (Debt / EBITDA) -----
Free Cash Flow -----
ROE (Net Profit / Equities) -----
Shareholders' equity1 -----
ROA (Net Profit / Asset) -----
Assets1 -----
Book Value Per Share2 2,001,492,422,742,97
Cash Flow per Share -----
Capex1 0,000,010,01--
Capex / Sales 0,15%1,19%1,47%--
Announcement Date 03/28/201903/10/202003/09/2021--
1 GBP in Million
2 GBP
Key data
Capitalization (GBP) 222 228 004
Capitalization (USD) 305 720 187
Net sales (GBP) 477 000
Net sales (USD) 655 684
Number of employees 12
Sales / Employee (GBP) 39 750
Sales / Employee (USD) 54 640
Free-Float 72,3%
Free-Float capitalization (GBP) 160 768 939
Free-Float capitalization (USD) 221 170 640
Avg. Exchange 20 sessions (GBP) 14 477 801
Avg. Exchange 20 sessions (USD) 19 901 185
Average Daily Capital Traded 6,51%
EPS & Dividend
Year-on-year evolution of the PER